I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ye, Zhuo-Miao
2071
results:
Online X
Search for persons
X
Format
Online (2071)
Mediatypes
Articles (Online) (1948)
Bookchapter (Online) (84)
OpenAccess-fulltext (39)
Languages
english (1843)
german (1)
Sorted by: Relevance
Sorted by: Year
?
1
Cost-effectiveness analysis of durvalumab plus chemotherapy..:
Ye, Zhuo-miao
;
Xu, Zhe
;
Li, Huan
.
Frontiers in Public Health. 11 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
2
m6A-related lncRNA-based immune infiltration characteristic..:
Wang, Hao-lun
;
Ye, Zhuo-miao
;
He, Zi-yun
..
Hereditas. 160 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
3
Cost-Effectiveness Analysis of Sintilimab Combined with Che..:
Ye, Zhuo-Miao
;
Xu, Zhe
;
Zeng, Fan-Yuan
..
Frontiers in Pharmacology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
4
Cost-effectiveness of nivolumab plus ipilimumab as first-li..:
Ye, Zhuo-miao
;
Tang, Zi-Qing
;
Xu, Zhe
..
Frontiers in Public Health. 10 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
5
Clinical analysis of 12 patients with primary lymphoepithel..:
Deng, Dong-feng
;
Zhou, Qin
;
Ye, Zhuo-miao
..
European Archives of Oto-Rhino-Laryngology. 279 (2021) 4 - p. 2003-2008 , 2021
Link:
https://doi.org/10.1007/..
?
6
Correction to: Clinical analysis of 12 patients with primar..:
Deng, Dong-feng
;
Zhou, Qin
;
Ye, Zhuo-miao
..
European Archives of Oto-Rhino-Laryngology. 279 (2021) 4 - p. 2009-2009 , 2021
Link:
https://doi.org/10.1007/..
?
7
A comprehensive assessment of single nucleotide polymorphis..:
Ye, Zhuo-Miao
;
Li, Li-Juan
;
Zheng, Jing-Hui
...
Medicine. 99 (2020) 24 - p. e20345 , 2020
Link:
https://doi.org/10.1097/..
?
8
A comprehensive evaluation of single nucleotide polymorphis..:
Ye, Zhuo-Miao
;
Luo, Ming-Bo
;
Zhang, Chi
...
Medicine. 99 (2020) 26 - p. e20486 , 2020
Link:
https://doi.org/10.1097/..
?
9
Profiles of immune cell infiltration and immune-related gen..:
Zhang, Chi
;
Zheng, Jing-Hui
;
Lin, Zong-Han
...
Aging. 12 (2020) 4 - p. 3486-3501 , 2020
Link:
https://doi.org/10.18632..
?
10
A systematic review and network meta-analysis of single nuc..:
Ye, Zhuo-Miao
;
Li, Li-Juan
;
Luo, Ming-Bo
...
Aging. 12 (2020) 24 - p. 25256-25274 , 2020
Link:
https://doi.org/10.18632..
?
11
A comprehensive evaluation of single nucleotide polymorphis..:
Tang, Zhen-Yu
;
Ye, Zhuo-Miao
;
Zheng, Jing-Hui
..
Medicine. 99 (2020) 29 - p. e20677 , 2020
Link:
https://doi.org/10.1097/..
?
12
m6A-related lncRNA-based immune infiltration characteristic..:
Wang, Hao-lun
;
Ye, Zhuo-miao
;
He, Zi-yun
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909974/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
Cost-Effectiveness Analysis of Sintilimab Combined with Che..:
Ye, Zhuo-Miao
;
Xu, Zhe
;
Zeng, Fan-Yuan
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742528/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
Cost-effectiveness analysis of durvalumab plus chemotherapy..:
Zhuo-miao Ye
;
Zhe Xu
;
Huan Li
.
https://www.frontiersin.org/articles/10.3389/fpubh.2023.1046424/full. , 2023
Link:
https://doi.org/10.3389/..
?
15
Data_Sheet_1_Cost-effectiveness analysis of durvalumab plus..:
Zhuo-miao Ye
;
Zhe Xu
;
Huan Li
.
doi:10.3389/fpubh.2023.1046424.s001. , 2023
Link:
https://doi.org/10.3389/..
1-15